Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03346135
Title	Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma
Recruitment	Active, not recruiting
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	City of Hope Medical Center
Indications	multiple myeloma
Therapies	Melphalan Daratumumab
Age Groups:	senior \| adult
Covered Countries	USA

Filter rows:

Showing 1 to 2 of 2 entries

Facility	Status	City	State	Zip	Country	Details
City of Hope Medical Center		Duarte	California	91010	United States	Details
Sarah Cannon Cancer Center		Nashville	Tennessee	37203	United States	Details

Showing 1 to 2 of 2 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field